Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 8, 2018

View Archived Issues

Blood protein networks linked to complex diseases

Multigene assay constructed to predict late recurrence in ER-positive breast cancer

Suppressive role of exosomal TRIM3 in gastric cancer growth: potential biomarker and therapy target

First patients dosed in phase I/II study of FX-322

Salvensis patents compounds for schistosomiasis

Resverlogix announces seventh positive recommendation for phase III study of apabetalone

Korean researchers divulge new antiviral compounds

Data analysis completed for second cohort in part I of phase I/IIa study of CRV-431

U.S. researchers identify ITGA5 antagonists

NHRI synthesizes new CXCR4 ligands

Sichuan Kelun-Biotech Biopharmaceutical patents FXR agonists

Neuroendocrine stress pathways mediate the adverse health effects of air pollution

Plant-derived compound silvestrol inhibits HEV replication with additive effect to ribavirin

FDA expands approval of Orkambi to children 2 to 5 years of age

Researchers present new anti-CRH MAb for AD downstream pathologies

ADC Therapeutics begins dosing in registrational phase II trial evaluating ADCT-402

DMC recommends early continuation of phase III GENESIS study of BL-8040

Recruitment underway in TaiRx's phase II study of CMV-118 in combination with sorafenib

New sulfonamide is potent anti-breast cancer agent

Aged rhesus monkey shows same pattern of tau pathology as humans

Teneobio and Poseida to use UniDabs to develop CAR-T therapies

New biological target for Alzheimer's identified in BioArctic/Eisai collaboration

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...